Mouth Ulcer Treatment Market (By Drug Class: Antimicrobial, Antihistamine, Analgesics & Corticosteroids; By Formulation: Gels, Lozenges) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global mouth ulcer treatment market size was surpassed at USD 1.62 billion in 2023 and is expected to hit around USD 2.39 billion by 2033, growing at a CAGR of 3.95% from 2024 to 2033.

Mouth Ulcer Treatment Market Size 2024 to 2033

Key Pointers

  • North America dominated the market with the largest revenue share of 37% in 2023.
  • Asia Pacific is expected to grow at the fastest CAGR of 5.05% from 2024 to 2033.
  • By Drug Class, the analgesics and corticosteroids segment dominated the market in 2023.
  • By Formulation, the gels segment held the largest share of 39% of the global revenue in 2023.

Mouth Ulcer Treatment Market Overview

The mouth ulcer treatment market is witnessing significant growth globally due to the rising prevalence of oral health issues and an increasing awareness regarding oral hygiene. Mouth ulcers, also known as canker sores, are a common oral condition characterized by painful sores or lesions in the mouth lining. These ulcers can be caused by various factors such as stress, injury, vitamin deficiencies, or underlying health conditions. As a result, the demand for effective treatment options to alleviate pain and promote healing has surged, driving the growth of the mouth ulcer treatment market.

Mouth Ulcer Treatment Market Growth Factors  

The growth of the mouth ulcer treatment market is propelled by the uptick in the prevalence of mouth ulcers globally, stemming from various lifestyle-related factors and dietary habits. Additionally, heightened awareness campaigns surrounding oral health have prompted individuals to seek treatment for oral conditions, including mouth ulcers, at an earlier stage. Technological advancements in treatment options, ranging from topical applications to advanced therapeutic procedures, have also contributed significantly to market expansion. Moreover, the increasing healthcare expenditure and accessibility to oral healthcare services further fuel market growth, as patients prioritize managing mouth ulcers effectively to alleviate discomfort and promote healing.

Report Scope of the Mouth Ulcer Treatment Market

Report Coverage Details
Revenue Share of North America in 2023 37%
CAGR of Asia Pacific from 2024 to 2033 5.05%
Revenue Forecast by 2033 USD 2.39 billion
Growth Rate from 2024 to 2033 CAGR of 3.95%
Base Year 2023
Forecast Period 2024 to 2033
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)

 

Mouth Ulcer Treatment Market Trends:

  • Growing Demand for Oral Health Awareness: There's a surge in awareness campaigns and educational initiatives aimed at promoting oral hygiene and preventive care, leading individuals to seek timely treatment for mouth ulcers.
  • Preference for Natural Remedies: There's a growing trend towards using natural and herbal remedies for mouth ulcer treatment, driven by concerns about side effects associated with conventional pharmaceuticals and a preference for holistic approaches to healthcare.
  • Expansion of Distribution Channels: The mouth ulcer treatment market is witnessing the expansion of distribution channels, with a significant shift towards online retailing and e-commerce platforms offering convenience and accessibility to a wider range of treatment products.
  • Personalized Treatment Approaches: Increasing emphasis is being placed on personalized treatment approaches, with healthcare providers tailoring therapies to individual patient needs and preferences, thereby improving treatment outcomes and patient satisfaction.
  • Integration of Telemedicine: The integration of telemedicine and virtual consultations is facilitating remote diagnosis and management of mouth ulcers, enabling patients to access healthcare services conveniently from their homes.
  • Research and Development: Ongoing research and development efforts in the field of oral healthcare are driving the discovery of novel therapeutic agents and treatment modalities for mouth ulcers, promising further advancements in the future.

Drug Class Insights

The analgesics and corticosteroids segment dominated the market in 2023 and is also expected to grow at the fastest CAGR over the forecast period from 2024 to 2033, owing to the high prescription rate of these products as painkillers in the global market. They are used as painkillers in the treatment of dental sores.

Corticosteroid has anti-inflammatory properties that help in lowering inflammation caused due to infection. In addition, it binds with intracellular receptors and alters gene expression, thereby inhibiting the action of microbes. Analgesics and corticosteroids are the most prescribed drug by doctors across the globe. These drugs are highly reliable for any kind of oral problem; therefore, this segment is estimated to experience lucrative growth.

Formulation Insights

Based on formulation, the mouth ulcers treatment market is divided into sprays, mouthwash, gels, and lozenges. The gels segment held the largest share of 39% of the global revenue in 2023 due to quick healing formulas, ease of availability, and fast anti-inflammatory & anti-swelling properties. They also have anesthetic properties that provide temporary relief from the excruciating pain of sores. It is available in a variety of flavors and forms that are suitable for both adults and children.

The sprays segment is expected to post the highest CAGR during the forecast period due to low side effects, ease of availability, and quick healing of sores. They can be taken regularly to minimize harmful effects. Adults also prefer taking these formulations, as the chances of getting side effects are low in comparison to other alternatives and they provide long-term protection.

Regional Insights

North America dominated the market with the largest revenue share of 37% in 2023. The rate of dental problems affecting people is considerably increasing in the U.S. This is attributed to an unhealthy diet, tobacco addiction, stress & trauma, and altered local immune responses. According to the United States Surgeon General's report, approximately 25% of the general population is affected by recurrent canker sores. Favorable government policies and initiatives by organizations such as the U.S. Department of Health and Human Services that are committed to boosting people's oral health across the country are anticipated to drive regional growth.

Asia Pacific is expected to grow at the fastest CAGR of 5.05% over the forecast period owing to increasing awareness about oral hygiene and supportive government initiatives. The region, on account of its wide population base and improving healthcare infrastructure, is anticipated to register the most promising growth rate during the forecast period. Besides this, vast untapped potential and increasing recognition & penetration of branded products are stimulating the growth of the regional market.

Rising awareness regarding oral treatment and practices is projected to spur the regional market growth. Moreover, increasing consumption of tobacco is expected to result in a large number of mouth ulcer cases. For instance, according to an article published by Our World in Data, nearly one in four adults in the world are daily smokers. Furthermore, the region records about 2.3 million annual deaths due to adverse effects of smoking. Increased susceptibility to mouth ulcers due to smoking is anticipated to boost the regional growth.

Mouth Ulcer Treatment Market Key Companies

  • Blistex, Inc.
  • Church & Dwight Co., Inc.
  • 3M
  • Colgate- Palmolive Company
  • GlaxoSmithKline, Plc
  • Bristol Myers Squibb Company
  • Pfizer, Inc.

Mouth Ulcer Treatment Market Segmentations:

By Formulation 

  • Sprays
  • Mouthwash
  • Gels
  • Lozenges

By Drug Class 

  • Antimicrobial
  • Antihistamine
  • Analgesics & Corticosteroids
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The global mouth ulcer treatment market size was reached at USD 1.62 billion in 2023 and it is projected to hit around USD 2.39 billion by 2033.

The global mouth ulcer treatment market is growing at a compound annual growth rate (CAGR) of 3.95% from 2024 to 2033.

The North America region has accounted for the largest mouth ulcer treatment market share in 2023.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Mouth Ulcer Treatment Market 

5.1. COVID-19 Landscape: Mouth Ulcer Treatment Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Mouth Ulcer Treatment Market, By Formulation

8.1. Mouth Ulcer Treatment Market, by Formulation, 2024-2033

8.1.1. Sprays

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Mouthwash

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Gels

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Lozenges

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Mouth Ulcer Treatment Market, By Drug Class

9.1. Mouth Ulcer Treatment Market, by Drug Class, 2024-2033

9.1.1. Antimicrobial

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Antihistamine

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Analgesics & Corticosteroids

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Mouth Ulcer Treatment Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.1.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.1.3.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.1.4.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.2.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.2.3.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.2.4.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.2.5.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.2.6.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.3.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.3.3.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.3.4.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.3.5.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.3.6.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.4.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.4.3.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.4.4.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.4.5.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.4.6.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.5.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.5.3.2. Market Revenue and Forecast, by Drug Class (2021-2033)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Formulation (2021-2033)

10.5.4.2. Market Revenue and Forecast, by Drug Class (2021-2033)

Chapter 11. Company Profiles

11.1. Blistex Inc.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Church & Dwight Co, Inc.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. 3M

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Colgate Palmolive Company

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. LTE Scientific

11.5. GlaxoSmithKline, plc

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Bristol-Myers Squibb Company

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Pfizer, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers